Berry Genomics Co.,Ltd (SHE:000710)

Berry Genomics Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	347.37	383.07	338.15	333.56	417.89	629.31
Trading Asset Securities	14.75	17.03	13.86	4.51	3.82	3.82
Cash & Short-Term Investments	362.11	400.1	352.01	338.07	421.7	633.12
Cash Growth	40.18%	13.66%	4.12%	-19.83%	-33.39%	35.19%
Accounts Receivable	685.68	694.72	815.21	1,063	1,109	1,071
Other Receivables	74.69	76.45	4.97	14.51	34.07	45.71
Receivables	760.37	771.17	820.18	1,077	1,143	1,117
Inventory	189.67	194.91	229.3	230.95	233.88	180.27
Prepaid Expenses	-	0.01	0.14	0.21	1.88	2.92
Other Current Assets	72.1	72.9	71.37	80.15	105.88	74.65
Total Current Assets	1,384	1,439	1,473	1,727	1,907	2,008
Property, Plant & Equipment	543.78	459.07	923.42	1,101	1,131	909.28
Long-Term Investments	180.36	177.19	48.45	138.26	279.07	167.14
Goodwill	13.43	13.43	13.43	13.43	13.43	13.43
Other Intangible Assets	30.5	31.68	49.67	51.6	52.21	53.9
Long-Term Deferred Tax Assets	144.07	144.07	151.27	104.8	63.93	26.36
Long-Term Deferred Charges	94.42	89.77	48.44	41.04	46.71	46.81
Other Long-Term Assets	30.42	30.42	33.49	26.66	27.05	19
Total Assets	2,421	2,385	2,741	3,203	3,520	3,244
Accounts Payable	238.34	287.51	292.48	278.9	339.93	243.29
Accrued Expenses	46.98	55.81	64.95	63.14	66.16	74.04
Short-Term Debt	125.06	113.42	202.64	203.69	190.54	123.11
Current Portion of Long-Term Debt	4.88	-	42.3	-	-	-
Current Portion of Leases	-	3.63	12.95	13	9.44	-
Current Income Taxes Payable	10.02	3.9	11.91	0.38	13.44	18.15
Current Unearned Revenue	100.5	103.49	110.75	103.56	90.55	71.19
Other Current Liabilities	22.19	22.81	25.11	42.05	58.52	26.66
Total Current Liabilities	547.96	590.56	763.09	704.72	768.58	556.43
Long-Term Debt	-	-	42.18	126.6	185.7	236.34
Long-Term Leases	133.83	43.24	3.5	4.88	13.62	-
Long-Term Unearned Revenue	10.87	10.87	11.02	12.07	3.66	4.85
Long-Term Deferred Tax Liabilities	24.84	24.9	26.77	25.89	24.46	23.91
Total Liabilities	717.51	669.56	846.56	874.17	996.02	821.52
Common Stock	353.52	353.52	353.52	354.61	354.61	354.61
Additional Paid-In Capital	1,154	1,159	1,156	1,211	1,160	1,061
Retained Earnings	138.93	145.39	337.82	765.02	1,020	1,131
Treasury Stock	-	-	-	-44.52	-44.52	-160.42
Comprehensive Income & Other	20.43	21.1	16.5	15.39	0.63	2.73
Total Common Equity	1,667	1,679	1,864	2,301	2,490	2,388
Minority Interest	36.36	35.69	30.57	27.94	33.51	34.01
Shareholders' Equity	1,704	1,715	1,895	2,329	2,524	2,422
Total Liabilities & Equity	2,421	2,385	2,741	3,203	3,520	3,244
Total Debt	263.77	160.28	303.58	348.17	399.3	359.44
Net Cash (Debt)	98.34	239.82	48.43	-10.11	22.4	273.68
Net Cash Growth	-	395.21%	-	-	-91.81%	28.94%
Net Cash Per Share	0.30	0.68	0.14	-0.03	0.06	0.77
Filing Date Shares Outstanding	353.52	353.52	353.52	353.52	353.52	350.7
Total Common Shares Outstanding	353.52	353.52	353.52	353.52	353.52	350.7
Working Capital	836.3	848.53	709.9	1,022	1,138	1,452
Book Value Per Share	4.72	4.75	5.27	6.51	7.04	6.81
Tangible Book Value	1,623	1,634	1,801	2,236	2,425	2,321
Tangible Book Value Per Share	4.59	4.62	5.09	6.33	6.86	6.62
Buildings	-	317.47	606.22	684.23	684.08	691.39
Machinery	-	623.32	638.82	591.45	553.45	542.23
Construction In Progress	-	-	230.8	290.95	267.6	3.75

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.